百利科技(603959.SH):控股股東擬轉讓5%股份予湘廣通達、轉讓6%股份予蘇歡
格隆匯9月16日丨百利科技(603959.SH)公佈,公司於2021年9月16日接到控股股東新海新投資通知,新海新投資於2021年9月14日與湘廣通達簽署了《股份轉讓協議1》,擬將其持有的公司無限售條件流通股2451.495萬股(佔公司總股本的5%)轉讓給湘廣通達;與蘇歡簽署《股份轉讓協議2》,擬將其持有的公司無限售條件流通股2941.79萬股(佔公司總股本的6%)轉讓給蘇歡。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.